Global and India Medical Imaging Contrast Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and India Medical Imaging Contrast Market Report & Forecast 2024-2034
Medical imaging contrast refers to substances or agents used to enhance the visibility and differentiation of structures or regions within the body during various medical imaging procedures. These substances increase the contrast between different tissues or fluids, allowing healthcare professionals to obtain clearer and more detailed images, aiding in diagnosis, treatment planning, and monitoring of medical conditions.
Examples include iodine-based agents for X-rays and CT scans, gadolinium-based agents for MRI, barium sulfate for GI tract X-rays, and microbubble agents for ultrasound.
Contrast agents can be administered orally, intravenously, or through other routes, depending on the imaging modality and the specific area of the body being examined. They work by altering the way X-rays, magnetic resonance (MR) signals, or ultrasound waves interact with different tissues, resulting in better visualization of anatomical structures or pathological changes.
The global Medical Imaging Contrast revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period (2024-2034).
In India, the Medical Imaging Contrast revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2024-2034).
The global key players of Medical Imaging Contrast include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma, Hengrui Medicine, Lantheus and YRPG, etc. The global five biggest players hold a share of % in 2022.
This report focuses on global and India Medical Imaging Contrast market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Medical Imaging Contrast will continue to grow rapidly in the future.
Global Medical Imaging Contrast Scope and Market Size
Medical Imaging Contrast market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Medical Imaging Contrast market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Medical Imaging Contrast market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Lantheus
YRPG
Segment by Type
Iodine-based Agents
Gadolinium-based Agents
Barium Sulfate
Others
Hospitals
Clinics
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Medical Imaging Contrast definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Medical Imaging Contrast companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Medical Imaging Contrast in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Imaging Contrast sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
Examples include iodine-based agents for X-rays and CT scans, gadolinium-based agents for MRI, barium sulfate for GI tract X-rays, and microbubble agents for ultrasound.
Contrast agents can be administered orally, intravenously, or through other routes, depending on the imaging modality and the specific area of the body being examined. They work by altering the way X-rays, magnetic resonance (MR) signals, or ultrasound waves interact with different tissues, resulting in better visualization of anatomical structures or pathological changes.
The global Medical Imaging Contrast revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period (2024-2034).
In India, the Medical Imaging Contrast revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2024-2034).
The global key players of Medical Imaging Contrast include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma, Hengrui Medicine, Lantheus and YRPG, etc. The global five biggest players hold a share of % in 2022.
This report focuses on global and India Medical Imaging Contrast market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Medical Imaging Contrast will continue to grow rapidly in the future.
Global Medical Imaging Contrast Scope and Market Size
Medical Imaging Contrast market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Medical Imaging Contrast market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Medical Imaging Contrast market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

By Company
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Lantheus
YRPG
Segment by Type
Iodine-based Agents
Gadolinium-based Agents
Barium Sulfate
Others
Segment by Application
Hospitals
Clinics
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Medical Imaging Contrast definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Medical Imaging Contrast companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Medical Imaging Contrast in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Imaging Contrast sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion
